Cresco Labs: Analysts Raise Targets Following Blowout Quarter
On November 18th, Cresco Labs (CSE: CL) reported their third quarter financial results. The company announced record revenue of $153.3
Read moreOn November 18th, Cresco Labs (CSE: CL) reported their third quarter financial results. The company announced record revenue of $153.3
Read moreLast week, Haywood Securities initiated coverage on Cresco Labs (CSE: CL) with a C$14.00 price target and a buy rating.
Read moreLast week Stifel released their Q3 earnings preview for all the MSO’s while stating that Green Thumb Industries (CSE: GTII),
Read moreThe upcoming US election has renewed interest in CSE-listed American cannabis operators, many of which are carving out new 52
Read moreOn the first of the month, Cowen and Co sent out an industry update specifically for the U.S. multi-state operators,
Read moreCresco Labs (CSE: CL) reported its second-quarter 2020 financials yesterday, posting revenue growth of 42% quarter over quarter to $94.3
Read moreEarlier this week, Stifel released a new report on cannabis operations, focused predominantly on US-based multi state operators, while re-initiating
Read moreThis morning PI Financial came out with their mid-year top picks for 2020. Among the picks were two cannabis stocks,
Read moreCresco Labs (CSE: CL) has seen one of its co-founders resign as of this morning. Originally reported late last night
Read moreCresco Labs (CSE:CL), has received change in ownership approval from the Massachusetts Cannabis Control Commission, and has thus finalized the
Read more